Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipoproteins, HDL | 4 | 2007 | 46 | 0.640 |
Why?
|
| Apolipoprotein A-I | 4 | 2002 | 21 | 0.540 |
Why?
|
| Diterpenes | 1 | 2015 | 92 | 0.490 |
Why?
|
| Homocysteine | 1 | 2007 | 19 | 0.300 |
Why?
|
| Methionine | 1 | 2007 | 30 | 0.300 |
Why?
|
| Lipoproteins | 3 | 2004 | 64 | 0.280 |
Why?
|
| Conotoxins | 1 | 2004 | 18 | 0.250 |
Why?
|
| Tyrosine | 1 | 2004 | 118 | 0.240 |
Why?
|
| Protein Subunits | 1 | 2004 | 87 | 0.240 |
Why?
|
| Receptors, Nicotinic | 1 | 2004 | 106 | 0.230 |
Why?
|
| Apolipoprotein A-II | 2 | 2000 | 2 | 0.230 |
Why?
|
| Triglycerides | 3 | 2002 | 138 | 0.220 |
Why?
|
| Cholesterol, Dietary | 2 | 2002 | 10 | 0.190 |
Why?
|
| Cholesterol, HDL | 4 | 2007 | 97 | 0.170 |
Why?
|
| Diet, Fat-Restricted | 1 | 1999 | 5 | 0.170 |
Why?
|
| Dietary Fats | 4 | 2004 | 119 | 0.170 |
Why?
|
| Sex Characteristics | 2 | 2002 | 230 | 0.170 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2016 | 61 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2016 | 83 | 0.130 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 70 | 0.130 |
Why?
|
| Metabolome | 1 | 2015 | 53 | 0.120 |
Why?
|
| Animals | 7 | 2016 | 15081 | 0.110 |
Why?
|
| Male | 9 | 2015 | 20025 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 767 | 0.100 |
Why?
|
| Cholesterol, VLDL | 2 | 2001 | 4 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1618 | 0.090 |
Why?
|
| Diet | 2 | 2007 | 801 | 0.090 |
Why?
|
| Female | 7 | 2015 | 20969 | 0.080 |
Why?
|
| Mice | 4 | 2007 | 5913 | 0.080 |
Why?
|
| Cholesterol | 3 | 2004 | 205 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2007 | 1609 | 0.070 |
Why?
|
| Apolipoproteins E | 1 | 2007 | 129 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2002 | 34 | 0.070 |
Why?
|
| Humans | 7 | 2015 | 37093 | 0.070 |
Why?
|
| Aged | 4 | 2002 | 6741 | 0.060 |
Why?
|
| Bungarotoxins | 1 | 2004 | 21 | 0.060 |
Why?
|
| Torpedo | 1 | 2004 | 41 | 0.060 |
Why?
|
| Radioligand Assay | 1 | 2004 | 66 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2004 | 111 | 0.060 |
Why?
|
| Fatty Acids | 2 | 2002 | 127 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 188 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2004 | 216 | 0.060 |
Why?
|
| Cell Line | 2 | 2004 | 1354 | 0.060 |
Why?
|
| Transfection | 1 | 2004 | 523 | 0.060 |
Why?
|
| Apolipoproteins | 1 | 2002 | 22 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 1 | 2002 | 4 | 0.050 |
Why?
|
| beta-Cyclodextrins | 1 | 2002 | 24 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 61 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2002 | 62 | 0.050 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2001 | 20 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2001 | 29 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2001 | 36 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2001 | 30 | 0.050 |
Why?
|
| Protein Binding | 1 | 2004 | 972 | 0.050 |
Why?
|
| Adult | 4 | 2004 | 11712 | 0.050 |
Why?
|
| Lipids | 1 | 2002 | 235 | 0.050 |
Why?
|
| Middle Aged | 3 | 2000 | 10129 | 0.050 |
Why?
|
| Tritium | 1 | 2000 | 51 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2002 | 305 | 0.050 |
Why?
|
| Leucine | 1 | 2000 | 29 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2002 | 381 | 0.040 |
Why?
|
| Apolipoprotein B-48 | 1 | 1999 | 7 | 0.040 |
Why?
|
| Apolipoproteins B | 1 | 1999 | 18 | 0.040 |
Why?
|
| Postmenopause | 1 | 2000 | 128 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 1999 | 68 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2002 | 517 | 0.040 |
Why?
|
| Kinetics | 1 | 1999 | 708 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 132 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2002 | 643 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2231 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 3483 | 0.020 |
Why?
|
| Fishes | 1 | 2004 | 53 | 0.010 |
Why?
|
| Particle Size | 1 | 2004 | 215 | 0.010 |
Why?
|
| Massachusetts | 1 | 2002 | 31 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 2002 | 31 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2002 | 36 | 0.010 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2002 | 1 | 0.010 |
Why?
|
| Androstenes | 1 | 2002 | 2 | 0.010 |
Why?
|
| Cyclodextrins | 1 | 2002 | 10 | 0.010 |
Why?
|
| Oleic Acid | 1 | 2002 | 19 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2002 | 8 | 0.010 |
Why?
|
| Receptors, Scavenger | 1 | 2002 | 15 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 42 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2002 | 23 | 0.010 |
Why?
|
| Cholesterol Esters | 1 | 2001 | 5 | 0.010 |
Why?
|
| Energy Intake | 1 | 2002 | 170 | 0.010 |
Why?
|
| Aorta | 1 | 2002 | 167 | 0.010 |
Why?
|
| Life Style | 1 | 2002 | 308 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2001 | 177 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 433 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1039 | 0.010 |
Why?
|
| Macrophages | 1 | 2002 | 439 | 0.010 |
Why?
|
| Liver | 1 | 2001 | 479 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2001 | 933 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 628 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 1742 | 0.010 |
Why?
|